Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement C1q is a large, multifunctional glycoprotein that serves as the recognition molecule of the classical pathway in the complement system. It is responsible for identifying and binding to various targets such as pathogens, immune complexes, apoptotic cells, and altered self-components. Its unique structure enables both direct pathogen recognition and interaction with multiple receptors. In addition to its canonical role in immunity via complement activation, it participates in non-inflammatory clearance processes critical for tissue homeostasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Component Subunit Q.